Targeted therapy using nanocomposite delivery systems in cancer treatment: highlighting miR34a regulation for clinical applications

Medicine and Dentistry

• microRNA 100%
• Metastatic Carcinoma 100%
• Cancer Therapy 100%
• Targeted Therapy 100%
• Nanocomposite 100%
• Cancer Growth 50%
• Programmed Cell Death 50%
• Tumor Suppressor Gene 50%
• Malignant Neoplasm 50%
• Drug Delivery System 50%
• Cancer Cell 50%
• Protein P53 50%
• Drug Resistance 50%
• Cancer Cell Line 50%
• Cell Proliferation 50%
• Gene Expression 50%
• Nanomedicine 50%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Programmed Cell Death 50%
• MicroRNA 50%
• Tumor Suppressor Gene 50%
• Transcription 50%
• P53 50%
• Cell Proliferation 50%
• Drug Resistance 50%
• Gene Expression 50%
• Cell Level 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Nanocomposite 100%
• microRNA 40%
• Cancer Growth 20%
• Tumor Suppressor Protein 20%
• Drug Delivery System 20%
• Drug Resistance 20%
• Protein P53 20%
• Metastasis 20%
• Nanomedicine 20%